Cytokines and chemokines as biomarkers of community-acquired bacterial infection

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Holub, Michal ^a   Lawrence, David A ^b   Andersen, Nancy ^b   Davidová, Alžběta ^a   Beran, Ondřej ^a   Marešová, Vilma ^c   Chalupa, Pavel ^a  

^a UNIVERSITY HOSPITAL BULOVKA   (Czech Republic)

^b WADSWORTH CENTER   (United States)

^c Kardiologie Na Bulovce S r o   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHEMOKINE; CYTOKINE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PROCALCITONIN; TUMOR NECROSIS FACTOR ALPHA; CALCITONIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; PROTEIN PRECURSOR;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; COMMUNITY; CONTROL GROUP; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SERUM; VIRUS INFECTION; ADOLESCENT; BLOOD; COMMUNITY ACQUIRED INFECTION; METABOLISM; MIDDLE AGED; VERY ELDERLY; YOUNG ADULT; COMMUNICABLE DISEASE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BACTERIAL INFECTIONS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; CHEMOKINES; COMMUNITY-ACQUIRED INFECTIONS; CYTOKINES; FEMALE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-2; INTERLEUKIN-4; INTERLEUKIN-6; INTERLEUKIN-8; MALE; MIDDLE AGED; PROTEIN PRECURSORS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84877274614     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/190145     Document Type: Article

References (30)

1. Linares L. F., Gomez-Reino J. J., Carreira P. E., C-reactive protein (CRP) levels in systemic lupus erythematosus (SLE). Clinical Rheumatology 1986 5 1 66 69 2-s2.0-0022641083 (Pubitemid 16167863)
2. Kanbayashi Y., Mukoyama N., Nishida K., Shimizu D., Matsumoto Y., Nomura K., Horiike S., Taniwaki M., Two cases of malignant lymphoma with high fever and C-reactive protein (CRP) elevation after treatment with granulocyte colony-stimulating factor (G-CSF). Cancer & Chemotherapy 2006 33 1 73 77 2-s2.0-33644822591
3. Gonzalez M. A., Selwyn A. P., Endothelial function, inflammation, and prognosis in cardiovascular disease. American Journal of Medicine 2003 115 8, supplement 99 106 2-s2.0-0348110529 10.1016/j.amjmed.2003.09.016 (Pubitemid 37532900)
4. Amin D. N., Pruitt J. C., Schuetz P., Influence of major cardiopulmonary surgery on serum levels of procalcitonin and other inflammatory markers. Anaesthesia and Intensive Care 2012 40 5 760 766
5. Nylén E. S., Al Arifi A., Becker K. L., Snider R. H. Jr., Alzeer A., Effect of classic heatstroke on serum procalcitonin. Critical Care Medicine 1997 25 8 1362 1365 2-s2.0-0030812322 10.1097/00003246-199708000-00024 (Pubitemid 27347301)
6. Lisboa T., Seligman R., Diaz E., Rodriguez A., Teixeira P. J. Z., Rello J., C-reactive protein correlates with bacterial load and appropriate antibiotic therapy in suspected ventilator-associated pneumonia. Critical Care Medicine 2008 36 1 166 171 2-s2.0-37549027197 10.1097/01.CCM.0000297886.32564.CF
7. Charles P. E., Tinel C., Barbar S., Aho S., Prin S., Doise J. M., Olsson N. O., Blettery B., Quenot J. P., Procalcitonin kinetics within the first days of sepsis: relationship with the appropriateness of antibiotic therapy and the outcome. Critical Care 2009 13 2, article R38 2-s2.0-64049119735 10.1186/cc7751
8. De Pablo R., Monserrat J., Reyes E., Diaz-Martin D., Rodriguez Zapata M., Carballo F., De La Hera A., Prieto A., Alvarez-Mon M., Mortality in patients with septic shock correlates with anti-inflammatory but not proinflammatory immunomodulatory molecules. Journal of Intensive Care Medicine 2011 26 2 125 132 2-s2.0-79953897079 10.1177/0885066610384465
9. Olszyna D. P., Prins J. M., Buis B., Van Deventer S. J. H., Speelman P., Van Der Poll T., Levels of inhibitors of tumor necrosis factor alpha and interleukin 1 β in urine and sera of patients with urosepsis. Infection and Immunity 1998 66 8 3527 3534 2-s2.0-0031848169 (Pubitemid 28347805)
10. Sekiyama K. D., Yoshiba M., Thomson A. W., Circulating proinflammatory cytokines (IL-1 β TNF- α and IL-6) and IL-1 receptor antagonist (IL-1Ra) in fulminant hepatic failure and acute hepatitis. Clinical and Experimental Immunology 1994 98 1 71 77 2-s2.0-0028139071 (Pubitemid 24315454)
11. de-Oliveira-Pinto L. M., Gandini M., Freitas L. P., Siqueira M. M., Marinho C. F., Setúbal S., Kubelka C. F., Cruz O. G., Oliveira S. A., Profile of circulating levels of IL-1Ra, CXCL10/IP-10, CCL4/MIP-1 β and CCL2/MCP-1 in dengue fever and parvovirosis. Memórias do Instituto Oswaldo Cruz 2012 107 1 48 56
12. Engel A., Kern P., Kern W. V., Levels of cytokines and cytokine inhibitors in the neutropenic patient with α -hemolytic streptococcus shock syndrome. Clinical Infectious Diseases 1996 23 4 785 789 2-s2.0-0029761321 (Pubitemid 26331125)
13. Urbonas V., Eidukaitė A., Tamulienė I., The diagnostic value of interleukin-6 and interleukin-8 for early prediction of bacteremia and sepsis in children with febrile neutropenia and cancer. Journal of Pediatric Hematology/Oncology 2012 34 2 122 127
14. McDade T. W., Tallman P. S., Adair L. S., Borja J., Kuzawa C. W., Comparative into the regulation of inflammation: levels and predictors of interleukin-6 and interleukin-10 in young adults in the Philippines. American Journal of Physical Antropology 2011 146 3 373 384
15. Yudkin J. S., Stehouwer C. D. A., Emeis J. J., Coppack S. W., C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arteriosclerosis, Thrombosis, and Vascular Biology 1999 19 4 972 978 2-s2.0-0032943709 (Pubitemid 29177345)
16. Esposito K., Nappo F., Marfella R., Giugliano G., Giugliano F., Ciotola M., Quagliaro L., Ceriello A., Giugliano D., Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 2002 106 16 2067 2072 2-s2.0-0037109184 10.1161/01.CIR.0000034509.14906.AE (Pubitemid 35192812)
17. Kolsuz M., Erginel S., Alataş O., Alataş F., Metintaş M., Uçgun I., Harmanci E., Çolak O., Acute phase reactants and cytokine levels in unilateral community-acquired pneumonia. Respiration 2003 70 6 615 622 2-s2.0-0942268170 10.1159/000075208 (Pubitemid 38142314)
18. Pierrakos C., Vincent J. L., Sepsis biomarkers: a review. Critical Care 2010 14 1, article R15 2-s2.0-77956628404 10.1186/cc8872
19. Chalupa P., Beran O., Herwald H., Kaspříková N., Holub M., Evaluation of potential biomarkers for the discrimination of bacterial and viral infections. Infection 2011 39 5 411 417
20. Endeman H., Meijvis S. C. A., Rijkers G. T., Van Velzen-Blad H., Van Moorsel C. H. M., Grutters J. C., Biesma D. H., Systemic cytokine response in patients with community-acquired pneumonia. European Respiratory Journal 2011 37 6 1431 1438 2-s2.0-79958017458 10.1183/09031936.00074410
21. Beran O., Lawrence D. A., Andersen N., Dzupova O., Kalmusova J., Musilek M., Holub M., Sequential analysis of biomarkers in cerebrospinal fluid and serum during invasive meningococcal disease. European Journal of Clinical Microbiology and Infectious Diseases 2009 28 7 793 799 2-s2.0-67349215684 10.1007/s10096-009-0708-6
22. Horcajada J. P., Velasco M., Filella X., Alvarez L., De Làzzari E., Marín J. L., Collvinent B., Smithson A., Martínez J. A., Noguero M., Vila J., Mensa J., Evaluation of inflammatory and renal-injury markers in women treated with antibiotics for acute pyelonephritis caused by Escherichia coli. Clinical and Diagnostic Laboratory Immunology 2004 11 1 142 146 2-s2.0-9144245354 10.1128/CDLI.11.1.142-146.2004 (Pubitemid 38090668)
23. Martínez R., Menéndez R., Reyes S., Polverino E., Cillóniz C., Martínez A., Esquinas C., Filella X., Ramírez P., Torres A., Factors associated with inflammatory cytokine patterns in community-acquired pneumonia. European Respiratory Journal 2011 37 2 393 399
24. Munford R. S., Pugin J., Normal responses to injury prevent systemic inflammation and can be immunosuppressive. American Journal of Respiratory and Critical Care Medicine 2001 163 2 316 321 2-s2.0-0035135739 (Pubitemid 32158505)
25. Blackwell T. S., Christman J. W., Sepsis and cytokines: current status. British Journal of Anaesthesia 1996 77 1 110 117 2-s2.0-0029944101 (Pubitemid 26229918)
26. Mera S., Tatulescu D., Cismaru C., Bondor C., Slavcovici A., Zanc V., Carstina D., Oltean M., Multiplex cytokine profiling in patients with sepsis. Acta Pathologica, Microbiologica, et Immunologica Scandinavica 2011 119 2 155 163 2-s2.0-78650835112 10.1111/j.1600-0463.2010.02705.x
27. de Jager C. P. C., van Wijk P. T. L., Mathoera R. B., de Jongh-Leuvenink J., van der Poll T., Wever P. C., Lymphocytopenia and neutrophil-lymphocyte count ratio predict bacteremia better than conventional infection markers in an emergency care unit. Critical Care 2010 14 5, article R192 2-s2.0-77958534644 10.1186/cc9309
28. Paris M. M., Friedland I. R., Ehrett S., Hickey S. M., Olsen K. D., Hansen E., Thonar E. J. M. A., McCracken G. H., Effect of interleukin-1 receptor antagonist and soluble tumor necrosis factor receptor in animal models of infection. Journal of Infectious Diseases 1995 171 1 161 169 2-s2.0-0028802018
29. Christian L. M., Iams J. D., Porter K., Glaser R., Inflammatory responses to trivalent influenza virus vaccine among pregnant women. Vaccine 2011 29 48 8982 8987
30. Bloos F., Hinder F., Becker K., Sachse S., Mekontso Dessap A., Straube E., Cattoir V., Brun-Buisson C., Reinhart K., Peters G., Bauer M., A multicenter trial to compare blood culture with polymerase chain reaction in severe human sepsis. Intensive Care Medicine 2010 36 2 241 247 2-s2.0-77951210696 10.1007/s00134-009-1705-z